Abstract:IMPORTANCE Obesity increases the severe COVID-19 risk. Whether obesity is associated with an increased risk of post-acute sequelae of SARS-Cov-2 infection (PASC) among pediatrics, independent of its impacts on acute infection severity, is unclear. OBJECTIVE To quantify the association between body mass index (BMI) status before SARS-CoV-2 infection and pediatric PASC risk, controlling for acute infection severity. DESIGN Retrospective cohort study occurred from March 2020 to May 2023, with a minimal follow-up of 179 days. SETTING Twenty-six US hospitals. PARTICIPANTS Individuals aged 5-20 years with SARS-CoV-2 infection. EXPOSURES Elevated BMI status assessed before infection. MAIN OUTCOMES AND MEASURES To identify PASC, we first used the ICD-10-CM code specific for post-COVID-19 conditions, and a second approach used clusters of symptoms and conditions that constitute the PASC phenotype. BMI was assessed within 18 months before infection; the measure closest to the index date was selected. Relative risk (RR) for BMI-PASC association was quantified by Poisson regression models, adjusting for sociodemographic, acute COVID severity, and other clinical factors. RESULTS Among the 172136 participants included, the median age of BMI assessment and cohort entry were 12.8 and 13.2 years, 1402 (0.8%) were identified as having PASC with the ICD-10-CM code, and 74317 (43.2%) had more than 1 incident occurrence of PASC symptoms and conditions. Compared with participants with a healthy weight, those who had overweight, obesity, and severe obesity had 4.7% (RR, 1.047; 95% CI, 0.868-1.263), 25.4% (RR, 1.254; 95% CI, 1.064-1.478) and 42.1% (RR, 1.421; 95% CI, 1.253-1.611) higher risk of PASC when identified using the diagnosis code, respectively. The risk for any occurrences of PASC symptoms and conditions also increased in overweight (RR, 1.030; 95% CI, 0.982-1.080), obesity (RR, 1.108; 95% CI, 1.064-1.154), and severe obesity (RR, 1.174; 95% CI, 1.138-1.213), and that for total incident occurrences increased, too, in overweight (RR, 1.053; 95% CI, 1.000-1.109), obesity (RR, 1.137; 95% CI, 1.088-1.188), and severe obesity (RR, 1.182; 95% CI, 1.142-1.223). CONCLUSIONS AND RELEVANCE Elevated BMI was associated with a significantly increased PASC risk in a dose-dependent manner. The biological mechanisms for this association should be investigated in future research.

The association of overweight, obesity, and long-term obesity with SARS-CoV-2 infection: a meta-analysis of 9 population-based cohorts from the Netherlands Cohorts Consortium

Obesity is Associated with Increased Severity of Disease in COVID-19 Pneumonia: a Systematic Review and Meta-Analysis

Obesity and age are transmission risk factors for SARS-CoV-2 infection among exposed individuals

Obesity Is Associated with Attenuated Tissue Immunity in COVID-19

Obesity, Inflammation, and Clinical Outcomes in COVID-19: A Multicenter Prospective Cohort Study

Diabetes and Overweight/Obesity Are Independent, Nonadditive Risk Factors for In-Hospital Severity of COVID-19: An International, Multicenter Retrospective Meta-analysis

Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients

Obesity as a Risk Factor for Complications and Mortality in Individuals with SARS-CoV-2: A Systematic Review

Overweight and Obesity as Predictors of Post-acute Sequelae of SARS-Cov-2 Infection: Findings from the RECOVER Initiative

Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics

Obesity aggravates COVID-19: An updated systematic review and meta-analysis

The association between excess weight and COVID-19 outcomes: An umbrella review

Obesity and Impaired Metabolic Health Increase Risk of COVID-19-Related Mortality in Young and Middle-Aged Adults to the Level Observed in Older People: The LEOSS Registry

Obesity is Associated with Worse Outcomes in COVID‐19: Analysis of Early Data from New York City

Obesity is Associated with Severe Forms of COVID‐19

Obesity as a predictor for a poor prognosis of COVID-19: A systematic review

Mid-regional proadrenomedullin, C-terminal proendothelin-1 values, and disease course are not different in critically ill SARS-CoV-2 pneumonia patients with obesity

Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships

Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review

The impact of obesity on COVID-19 complications: a retrospective cohort study

The impact of obesity on immune response to infection: Plausible mechanisms and outcomes